However, when we compared TH1/17 and TH17 cells between MS and controls, IL10 was reduced in TH1/17 and TH17 cells in patients (Fig. 6d, lower panel), though no difference was detected with TBX21 expression (Fig. 6c, lower panel). The gene discussed is IL10; the disease is myeloid sarcoma.